TRDA vs XLE
Entrada Therapeutics Inc (TRDA) versus Energy Select Sector SPDR® Fund (XLE) — a side-by-side from cached financials, not a winner call.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Energy Select Sector SPDR® Fund (XLE) common stock listed on US.
Latest reported TRDA revenue for 2026-06-30 was $1.8M. Net income was -$82.5M. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
XLE does not have a complete income-statement cache yet.
TRDA currently screens at market cap $274.4M and trailing P/E 12.5. XLE currently screens at market cap $0.
Not investment advice. Open the TRDA and XLE stock pages for the full models.
Not investment advice.